The Hematology Residency Training Program is proud to provide an extremely strong training experience that is fully accredited by the Royal College of Physicians and Surgeons of Canada. The residents that complete our program have a sound knowledge base and become competent and self reliant hematologists after a two year training program.
Our program benefits from having a strong Bone Marrow Transplant Program (in particular, a second-to-none inter-disciplinary team providing innovative, high quality, ethical and empathic care) as well as an internationally renowned Thrombosis Program with world-class research funding and productivity. Few programs in the country can boast strengths in both these content areas of clinical hematology (malignant hematology and thrombosis) and these two important aspects of academic life (patient care and research). We provide a great degree of flexibility in the Residency Training Program in order to meet the career needs of our candidates, with up to 8 months of elective time for each resident to individualize their program based on their particular interest in the field (research, education, subspecialties).
The division is extremely supportive of the Hematology Training Program with a strong commitment to education and the CanMEDS philosophy. At the completion of each of the rotations, residents are evaluated based on the CanMEDS framework set forth by the Royal College. Strengths of our educational program include well-organised weekly academic sessions with faculty involvement, a culture of ongoing formative evaluation and unique longitudinal clinics that teach residents to become independent medical experts in hematology. The best measure of success in our program is the success of our graduates. Our graduates have done well in their RCPS examinations and have established successful careers in a wide variety of areas from careers in community hematology to basic scientists in leukemia research.
The Thrombosis Clinical Fellowship program of the Division of Hematology at the University of Ottawa is based in an active, academic, tertiary care subspecialty service. The Thrombosis Program and its members are engaged in a wide variety of innovative clinical and research activities in the areas of (1) Diagnosis and treatment of venous and arterial thromboembolic disease and (2) Management of thrombophilia. Areas of research activity include basic science, clinical health, economic and outcomes research.
The objectives of the Clinical Fellowship are to train high level specialists in thrombosis. The fellows are expected to develop an in-depth knowledge of the physiology, pathology, diagnosis and treatment of thrombotic diseases through a variety of activities, including direct inpatient and outpatient care, clinical and basic research and other academic activities.
The Thrombosis Program at the Ottawa Hospital runs daily Thrombosis Clinics (365 days/year) with referrals from Ottawa and surrounding communities. There are approximately 13,000 visits per year for investigation or treatment for venous thrombosis, thrombophilia or anticoagulation management. In addition, we provide consult service to > 1000 in-patients at 2 campuses of the Ottawa Hospital (~1000 patient beds). The expectation is that at the end of training you will be able to perform as an expert thrombosis consultant.
The general objective for the fellows is to acquire clinical skills pertaining to the diagnosis and treatment of thrombotic diseases including but not limited to diagnosis (clinical, lab and imaging) of deep vein thrombosis, pulmonary embolism, other thrombotic disease, thrombophilia (acquired and genetic) and peri-operative anticoagulation.
Specific objectives are to demonstrate expertise in:
The fellows will be evaluated on the basis of their accomplishment of the objectives outlined above using a daily appraisal of the fellow‚Äôs skills as well as a formal appraisal of the academic activities in which he will be involved (i.e. rounds).
In order to standardize evaluations for trainees within the Division of Hematology, Thrombosis Fellows will be evaluated using the electronic One45 system through the University of Ottawa. Evaluations for outpatient clinics will occur every 6 months and for in-patient services will be completed monthly. Individual meetings with Thrombosis Fellows will take place every 6 months to review and discuss the evaluations.
At the end of the fellowship clinical fellows should be able to:
¬†< More info coming soon >
|Hematology Residency||Thrombosis Fellowship¬†||Malignant Hematology Fellowship¬†|
|Program Director||¬†Dr. Dimitri Scarvelis||¬†Dr. Marc Carrier||¬†Dr. Andrea Kew|
|Telephone||¬†(613) 737-8899 x 71059||¬†(613) 737-8899 x 73034||¬†(613) 737-8899 x 71281|
|Assistant||¬†Bonnie Legare||¬†Cathy McSheffery||¬†Cindy Brassard|
Education Coordinator: Alycia-Anne Martin